Dyne Therapeutics, Inc. (DYN)
25.99
-0.11
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
26.00
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Vor Biopharma, Inc. | -- |
| Neurocrine Biosciences, Inc. | 95.87% |
| Recursion Pharmaceuticals, Inc. | -202.4% |
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -68.30% |
| Return on Assets | -53.47% |
| Return on Invested Capital | -56.19% |
| Return on Net Operating Assets | -1.25K% |